S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, disrupting traffic in the global waterway
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, disrupting traffic in the global waterway
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, disrupting traffic in the global waterway
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, disrupting traffic in the global waterway
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
NASDAQ:DKDCA

Data Knights Acquisition (DKDCA) Stock Forecast, Price & News

$10.80
0.00 (0.00%)
(As of 06/2/2023 ET)
Compare
Today's Range
$10.80
▼
$10.80
50-Day Range
$10.66
▼
$10.96
52-Week Range
$10.22
▼
$10.98
Volume
21 shs
Average Volume
9,820 shs
Market Capitalization
$81.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

DKDCA stock logo

About Data Knights Acquisition (NASDAQ:DKDCA) Stock

Data Knights Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the data centers and internet technology sectors. The company was incorporated in 2021 and is based in Chessington, the United Kingdom.

Receive DKDCA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Data Knights Acquisition and its competitors with MarketBeat's FREE daily newsletter.

DKDCA Stock News Headlines

May 23, 2023 | americanbankingnews.com
Comparing U.S. Stem Cell (OTCMKTS:USRM) and Data Knights Acquisition (NASDAQ:DKDCA)
May 17, 2023 | americanbankingnews.com
Analyzing Data Knights Acquisition (NASDAQ:DKDCA) & Absci (NASDAQ:ABSI)
June 4, 2023 | Behind the Markets (Ad)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
May 11, 2023 | americanbankingnews.com
Data Knights Acquisition (DKDCA) & Its Rivals Financial Review
May 9, 2023 | americanbankingnews.com
Head-To-Head Contrast: Data Knights Acquisition (DKDCA) & Its Rivals
May 5, 2023 | americanbankingnews.com
Reviewing Data Knights Acquisition (DKDCA) & Its Rivals
May 3, 2023 | americanbankingnews.com
Data Knights Acquisition (DKDCA) vs. Its Peers Critical Review
May 3, 2023 | americanbankingnews.com
Head-To-Head Analysis: Data Knights Acquisition (DKDCA) and Its Rivals
June 4, 2023 | Legacy Research (Affiliate) (Ad)
“One-Stock Millionaire” IGNORES 99.9% of the Market
During the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.
April 29, 2023 | americanbankingnews.com
Head to Head Survey: Data Knights Acquisition (DKDCA) & Its Competitors
April 29, 2023 | americanbankingnews.com
Contrasting Data Knights Acquisition (DKDCA) and Its Rivals
April 28, 2023 | americanbankingnews.com
Analyzing Data Knights Acquisition (DKDCA) & The Competition
April 28, 2023 | americanbankingnews.com
Data Knights Acquisition (NASDAQ:DKDCA) & National Research (NASDAQ:NRC) Financial Contrast
April 28, 2023 | americanbankingnews.com
Head to Head Analysis: Data Knights Acquisition (DKDCA) versus Its Peers
April 26, 2023 | americanbankingnews.com
Financial Review: Data Knights Acquisition (DKDCA) versus The Competition
April 26, 2023 | americanbankingnews.com
Head to Head Contrast: Data Knights Acquisition (DKDCA) versus The Competition
April 25, 2023 | americanbankingnews.com
Data Knights Acquisition (DKDCA) and Its Rivals Head-To-Head Comparison
April 25, 2023 | americanbankingnews.com
Financial Analysis: Data Knights Acquisition (DKDCA) and Its Peers
April 24, 2023 | americanbankingnews.com
Data Knights Acquisition (DKDCA) vs. Its Competitors Financial Comparison
April 24, 2023 | americanbankingnews.com
Analyzing Data Knights Acquisition (DKDCA) & Its Peers
April 23, 2023 | americanbankingnews.com
Data Knights Acquisition (DKDCA) versus The Competition Critical Contrast
April 23, 2023 | americanbankingnews.com
Head-To-Head Survey: Data Knights Acquisition (DKDCA) and The Competition
April 23, 2023 | americanbankingnews.com
Data Knights Acquisition (DKDCA) vs. The Competition Head-To-Head Survey
April 21, 2023 | americanbankingnews.com
Analyzing Data Knights Acquisition (DKDCA) & Its Competitors
April 19, 2023 | americanbankingnews.com
Financial Analysis: Data Knights Acquisition (DKDCA) & The Competition
April 18, 2023 | americanbankingnews.com
Data Knights Acquisition (DKDCA) and Its Competitors Financial Survey
April 17, 2023 | americanbankingnews.com
Data Knights Acquisition (DKDCA) & Its Competitors Head to Head Comparison
See More Headlines

DKDCA Price History

DKDCA Company Calendar

Today
6/03/2023
Next Earnings (Estimated)
8/21/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Commercial physical research
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:DKDCA
CUSIP
N/A
CIK
1849380
Web
N/A
Phone
011-44-20-3833-4000
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.13)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$340,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-4.45%
Return on Assets
-2.61%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.07 per share
Price / Cash Flow
155.07
Book Value
($1.25) per share
Price / Book
-8.64

Miscellaneous

Outstanding Shares
7,570,000
Free Float
5,821,000
Market Cap
$81.76 million
Optionable
Not Optionable
Beta
0.02

Key Executives

  • Mr. Barry Anderson (Age 45)
    Chairman & CEO
  • Mr. Firdauz Edmin Bin Mokhtar (Age 49)
    CFO & Sec.

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













DKDCA Stock - Frequently Asked Questions

How have DKDCA shares performed in 2023?

Data Knights Acquisition's stock was trading at $10.44 at the beginning of the year. Since then, DKDCA stock has increased by 3.4% and is now trading at $10.80.
View the best growth stocks for 2023 here.

Are investors shorting Data Knights Acquisition?

Data Knights Acquisition saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 3,900 shares, an increase of 8.3% from the April 30th total of 3,600 shares. Based on an average trading volume of 3,300 shares, the short-interest ratio is presently 1.2 days. Currently, 0.2% of the shares of the stock are sold short.
View Data Knights Acquisition's Short Interest.

When is Data Knights Acquisition's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 21st 2023.
View our DKDCA earnings forecast.

What is Data Knights Acquisition's stock symbol?

Data Knights Acquisition trades on the NASDAQ under the ticker symbol "DKDCA."

Who are Data Knights Acquisition's major shareholders?

Data Knights Acquisition's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Shaolin Capital Management LLC (5.28%), Graham Capital Wealth Management LLC (2.44%), Atlas Merchant Capital LLC (1.72%), Wolverine Asset Management LLC (1.59%), Mizuho Securities USA LLC (1.32%) and SkyView Investment Advisors LLC (1.25%).

How do I buy shares of Data Knights Acquisition?

Shares of DKDCA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Data Knights Acquisition's stock price today?

One share of DKDCA stock can currently be purchased for approximately $10.80.

How much money does Data Knights Acquisition make?

Data Knights Acquisition (NASDAQ:DKDCA) has a market capitalization of $81.76 million. The company earns $340,000.00 in net income (profit) each year or ($0.13) on an earnings per share basis.

How many employees does Data Knights Acquisition have?

The company employs 2,021 workers across the globe.

How can I contact Data Knights Acquisition?

The company can be reached via phone at 011-44-20-3833-4000.

This page (NASDAQ:DKDCA) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -